This content is intended for use by healthcare professionals.
This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate
Beriplex® P/N (known in some areas as Confidex®) is indicated for:
Treatment and perioperative prophylaxis of bleeding in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin K antagonists, or in case of overdose of vitamin K antagonists (e.g. warfarin), when rapid correction of the deficiency is required. Treatment and perioperative prophylaxis of bleedings in congenital deficiency of any of the vitamin K-dependent coagulation factors when purified specific coagulation factor products are not available.
In the U.S., this product has been approved as
(Prothrombin Complex Concentrate [Human]) and is indicated for the urgent reversal of vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding or needing an urgent surgery or other invasive procedure.